Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
42 Cards in this Set
- Front
- Back
neurotransmitters important for hypothalamic peptidergic secretory cells
|
dopamine
norepinephrine serotonin |
|
paraventricular nucleus
supraoptic nucleus |
secretory neurons to posterior pituitary
|
|
genes necessary for formation of rathke's pouch and early pituitary development
|
PITX2, HESX1, LHX4
|
|
LHX3 gene
|
needed for differentiation of gondadotropes, thyrotropes, lactotrope, somatrotrope
all pituitary cell types EXCEPT corticotrope (ACTH) |
|
what genes are needed for development of corticotroph specifically
|
TPIT, NEURO D1
|
|
mutation in SF1 would stop development of which type of pituitary cell
|
gonadotroph
|
|
PROP1 and PITI genes
|
needed for differentiation into thyrotrophs (also need GATA2), lactotroph (also need ER), somatotroph
|
|
acidotrophs make
|
GH or Prolactin
|
|
pro-opiomelanocortin is processed into what in the anterior pituitary
|
N- terminal fragment
ACTH Beta-LPH ____ ACTH can be converted further in the intermediate lobe to MSH + CLIP Beta-LPH converted in the intermediate lobe to gamma-LPH, beta-endorphins, gamma-MSH, Met-Enk |
|
CRH is released due to
|
STRESS (emotional, physical, chemical, etc)
Time - higher in the morning before waking hypoglycema VASOPRESSIN* |
|
why does high ACTH cause hyperpigmentation
|
conversion to MSH in intermediate lobe -> stimulates melanocytes
|
|
plasma ACTH is pulsitile or non-pusitile
|
pulsitile
increased pulses -> more ACTH |
|
if lack corticotrophs, why is surgery dangerous
|
any trauma is dangerous if dont have high enough cortisol
|
|
how to check pituitary function test with insulin
|
give insulin
blood glucose will drop cortisol, GH should increase |
|
mutation of HESX-1 would cause
|
panhypopituitarism
|
|
tumor compressing stalk of piuititary would do what to the hormone release
|
all hormones would decrease except prolactin which would increase (due to decreased dopamine from hypothalamus)
|
|
patient with poor growth could have what levels of thyorid, GH, and cortisol?
|
low Thyroid hormone
low growth hormone high cortisol |
|
addisons disease
|
chronic primary adrenal insufficiency
ACTH excess due to unresponsive adrenals fatigue anorexia weight loss salt carving (low aldosterone) hyperpigmentation (due to high ACTH) |
|
nelson's syndrome
|
removal of both adrenal glands -> low cortisol -> lack neg feedback on any pituitary adenoma -> overgrowth of pituitary adenoma
--> mass effect, increased hyperpigmentation due to increased ACTH |
|
which hormones share the same alpha subunit
|
TSH, FSH, LH, beta-HCG
beta unit is specific |
|
important of thyroid hormone in development
|
CNS maturation
|
|
GNAS1
|
Gs alpha membrane associated protein
mutation can cause constitutive activation |
|
T/F continuous GnRH infusion will increase LH
|
False - continuous infusion will decrease LH
pulses of GnRH will increase LH |
|
early stage of puberty and LH
|
see increase in GnRH and LH pulse at night only - elevated during sleep
in the morning see high testosterone |
|
turner's syndrome
|
only one X chromosome - XO
not enough SHOX gene - resistance to growth see high FSH see short stature, short 4th and 5th metacarpals,pigmented nevi complications - primary ovarian failure, coarctation of aorta, renal abnormalities (horseshoe kidney) |
|
T/F if you find one problem in pituitary then you should evaluate all
|
true
|
|
which pituitary hormones use cytokine receptors (JAK/STAT)
|
GH, prolactin
|
|
IGF-1
|
secreted from liver in response to GH
important for bone and tissue growth |
|
factors that increase GH secretion
|
hypoglycemia
GHRH alpha-adrenergic agonist beta-adrenergic antagonist ghrelin sleep exercise stress |
|
factors that decrease GH secretion
|
postrandial hyperglycemia
elevated fatty acid somatostatin |
|
ghrelin
|
emptys stomach
causes GH secretion makes you hungry (via neuropeptide Y and agouti related protein from hypothalamus) stops fat utilizaiton in adipose cell secreted from stomach mostly |
|
most important regulator of prolactin secretion
|
dopamine NEGATIVELY affects prolactin secretion
more dopamine means less prolactin levadopa, bromocrtiptine, pergolide, carbergoline = dopamine agonist -> supress prolactin |
|
factors that affect prolectin secretion
|
increased by:
pregnancy breast feeding exercise stress sleep TRH Estrogen Dopamine angatonist monoamine oxidase inhibitor H2 angatonist opiods |
|
which releasing factor from the hypothalamus increases prolactin
|
TRH
|
|
drugs that increase prolactin secretion
|
dopamine antagonist:
phenoothiazine haloperidol metoclopramide H2 antagonist: cimetidine MAO inhibitors |
|
KALLMANN syndrome
|
hypogonadotropin hypogonadism
KAL gene mutation - abnormal migration of GnRH secreting neurons in the hypothalamus (also for olfactory nerve) symptoms: anosmia (lack of sense of smell) delayed puberty lack of strength |
|
most common cause of hyperprolactinemia
|
pregnancy
|
|
symptoms of hyperprolactinemia
|
amenorrhea
infertility due to anovulation - inhibits GnRH glactorrhea hypogonadism |
|
cabergoline
|
dopamine agonist - shrinks prolacinomas
can cause cardiac valve problems - by increasing quiescent valve cells |
|
excess growth hormone consqeunces
|
gigantism - in children before epiphyseal closure - tall, large hands and feet, fast linear growth
acromegally - after epiphyseal closure look: acral enlargement, coarse facial features, prominent supraorbital ridges, porgnathism (enlarged jaw) clinically: acanthosis, hyperinsulinemia, cardiovascular problems 90% due to pituitary adenoma |
|
treatment of acromegaly
|
somatostatin analog - octreotide
GH receptor antagonist - pegvisomant - prevents dimerization of cytokine receptor Dopamine agonist - cabergoline |
|
maccune albright syndrome
|
mutation in GNAS1 gene on Chr. 20 -> lack GPTase activity - causing constitutive activation of G-protein
means dont need TSH, GH, TRH to be acctive see increased thyroid hormone, incresaed growth hormone goiter, cafe au lait mark, fibrous dysplasia of bones, |